Profile Picture

Gangadhara Ganapati - Profile

Gangadhara Ganapati, Director, with 7 companies across 2 industries.

About Gangadhara Ganapati

Gangadhara Ganapati has 22 years in corporate governance. Holds Director role. Currently with 2 companies, including Mitosciences Research Private Limited and Triesta Sciences (India) Private Limited. Formerly with 5 companies, such as Bacc Health Care Private Limited and Adamas India Pharmaceuticals Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.

Current Companies 2
Past Companies 5
Total Affiliations 7
Oldest Company Age 22
Companies Associated with Gangadhara Ganapati
Current Companies
Previous Companies

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions
Who is Gangadhara Ganapati?

Gangadhara Ganapati has 22 years in corporate governance. Holds Director role. Currently with 2 companies, including Mitosciences Research Private Limited and Triesta Sciences (India) Private Limited. Formerly with 5 companies, such as Bacc Health Care Private Limited and Adamas India Pharmaceuticals Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.

What is Gangadhara Ganapati's role in current companies?

Gangadhara Ganapati is associated with 2 companies as Director.

What industries does Gangadhara Ganapati specialize in?

Gangadhara Ganapati has expertise in General Business, Healthcare.

How many years of experience does Gangadhara Ganapati have?

Gangadhara Ganapati has 22 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available